CRSP
Price
$44.20
Change
+$2.69 (+6.48%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
3.77B
27 days until earnings call
VERV
Price
$7.80
Change
+$1.23 (+18.72%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
660.38M
35 days until earnings call
Ad is loading...

CRSP vs VERV

Header iconCRSP vs VERV Comparison
Open Charts CRSP vs VERVBanner chart's image
CRISPR Therapeutics AG
Price$44.20
Change+$2.69 (+6.48%)
Volume$43.96K
Capitalization3.77B
Verve Therapeutics
Price$7.80
Change+$1.23 (+18.72%)
Volume$67.67K
Capitalization660.38M
CRSP vs VERV Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. VERV commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (CRSP: $41.51 vs. VERV: $6.57)
Brand notoriety: CRSP and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 99% vs. VERV: 133%
Market capitalization -- CRSP: $3.77B vs. VERV: $660.38M
CRSP [@Biotechnology] is valued at $3.77B. VERV’s [@Biotechnology] market capitalization is $660.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 2 bearish.
  • VERV’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, both CRSP and VERV are a good buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а +8.21% price change this week, while VERV (@Biotechnology) price change was +25.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +2.45%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.77B) has a higher market cap than VERV($660M). VERV YTD gains are higher at: 16.489 vs. CRSP (5.462). VERV has higher annual earnings (EBITDA): -219.97M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. VERV (540M). VERV has less debt than CRSP: VERV (71.3M) vs CRSP (228M). CRSP has higher revenues than VERV: CRSP (200M) vs VERV (24.4M).
CRSPVERVCRSP / VERV
Capitalization3.77B660M572%
EBITDA-313.08M-219.97M142%
Gain YTD5.46216.48933%
P/E RatioN/AN/A-
Revenue200M24.4M820%
Total Cash1.94B540M359%
Total Debt228M71.3M320%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPVERV
RSI
ODDS (%)
Bullish Trend 15 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 15 days ago
77%
Bearish Trend 15 days ago
90%
Momentum
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 15 days ago
88%
MACD
ODDS (%)
Bullish Trend 15 days ago
72%
Bullish Trend 15 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 15 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 15 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEMRX9.190.13
+1.43%
Janus Henderson Emerging Markets N
ACLAX15.990.18
+1.14%
American Century Mid Cap Value A
GSMGX15.18N/A
N/A
Goldman Sachs Small/Mid Cap Growth C
NWAPX34.33N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc Egl
KCIIX12.50N/A
N/A
Knights of Columbus International Eq I

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+2.42%
BEAM - CRSP
71%
Closely correlated
+4.65%
RXRX - CRSP
64%
Loosely correlated
+5.36%
PRME - CRSP
63%
Loosely correlated
+0.69%
NTLA - CRSP
61%
Loosely correlated
+4.63%
EDIT - CRSP
59%
Loosely correlated
-0.82%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+7.00%
BEAM - VERV
54%
Loosely correlated
+4.65%
CRSP - VERV
53%
Loosely correlated
+2.42%
PRME - VERV
49%
Loosely correlated
+0.69%
EDIT - VERV
49%
Loosely correlated
-0.82%
NTLA - VERV
48%
Loosely correlated
+4.63%
More